Figures & data
![](/cms/asset/95b15ba7-9d98-47b1-a7de-99d27c378027/kbie_a_2090379_uf0001_oc.jpg)
Figure 1. Characterization of exosomes and FGL1 expression. (a) Morphology of purified exosomes; (b) The hydrodynamic size of the exosomes was measured using an NTA; (c) exosome markers CD9, CD63 and CD81 were detected by Western blot; (d) FGL1 expression were detected by Western blot. *p < 0.05 vs. Control group.
![Figure 1. Characterization of exosomes and FGL1 expression. (a) Morphology of purified exosomes; (b) The hydrodynamic size of the exosomes was measured using an NTA; (c) exosome markers CD9, CD63 and CD81 were detected by Western blot; (d) FGL1 expression were detected by Western blot. *p < 0.05 vs. Control group.](/cms/asset/846187bb-7ea0-490e-be57-95dc5c3470d6/kbie_a_2090379_f0001_oc.jpg)
Figure 2. Overexpression of FGL1 attenuated the cell viability and apoptosis in RA-FLSs. (a) Representative fluorescence images of exosomes were englobed by FLSs; (b) Cell viability was detected by CCK-8 assay; (c) Cell apoptosis was detected by Flow cytometry. *p < 0.05 vs. Control group; #p < 0.05 vs. Model group; @p < 0.05 vs. BM-MSCs-Exos group.
![Figure 2. Overexpression of FGL1 attenuated the cell viability and apoptosis in RA-FLSs. (a) Representative fluorescence images of exosomes were englobed by FLSs; (b) Cell viability was detected by CCK-8 assay; (c) Cell apoptosis was detected by Flow cytometry. *p < 0.05 vs. Control group; #p < 0.05 vs. Model group; @p < 0.05 vs. BM-MSCs-Exos group.](/cms/asset/2ab76ecf-9d83-4e3e-97f3-c0353bf769d1/kbie_a_2090379_f0002_oc.jpg)
Figure 3. Overexpression of FGL1 attenuated the inflammatory cytokines and NF-κB relative protein expressions. (a) MMP-9 expression; (b) IL-1β expression; (c) IL-8 expression; (d) IL-17 expression; (e, f) p-NF-κBp65 and NF-κBp65 expressions were detected by Western blot; (g) Western blot images; (h) p-IκBα/IκBα; (i) Bcl-2/Bax; (j) cleaved-caspase 3 expression. *p < 0.05 vs. Control group; #p < 0.05 vs. Model group; @p < 0.05 vs. BM-MSCs-Exos group.
![Figure 3. Overexpression of FGL1 attenuated the inflammatory cytokines and NF-κB relative protein expressions. (a) MMP-9 expression; (b) IL-1β expression; (c) IL-8 expression; (d) IL-17 expression; (e, f) p-NF-κBp65 and NF-κBp65 expressions were detected by Western blot; (g) Western blot images; (h) p-IκBα/IκBα; (i) Bcl-2/Bax; (j) cleaved-caspase 3 expression. *p < 0.05 vs. Control group; #p < 0.05 vs. Model group; @p < 0.05 vs. BM-MSCs-Exos group.](/cms/asset/43307047-5501-4e26-8f1f-deced986bded/kbie_a_2090379_f0003_b.gif)
Figure 4. Overexpression of FGL1 attenuated paw and Knee arthritis scores and Knee joint histopathology in RA rat model. (a) Macroscopic images of paws; (b) Paw thickness; (c) Mean arthritis scores; (d) Knee joint histopathology were detected by HE and Safranin O stain. *p < 0.05 vs. Control group; #p < 0.05 vs. Model group; @p < 0.05 vs. BM-MSCs-Exos group.
![Figure 4. Overexpression of FGL1 attenuated paw and Knee arthritis scores and Knee joint histopathology in RA rat model. (a) Macroscopic images of paws; (b) Paw thickness; (c) Mean arthritis scores; (d) Knee joint histopathology were detected by HE and Safranin O stain. *p < 0.05 vs. Control group; #p < 0.05 vs. Model group; @p < 0.05 vs. BM-MSCs-Exos group.](/cms/asset/3f68652a-ff4a-407a-ab24-fd0130e459d3/kbie_a_2090379_f0004_oc.jpg)
Figure 5. Overexpression of FGL1 attenuated inflammatory cytokines, specific rheumatoid markers and immunological markers expressions in RA rat model. (a) MMP-9 expression; (b) IL-1β expression; (c) IL-8 expression; (d) IL-17 expression; (e) RF expression; (f) MMP-3 expression; (g) CRP expression; (h) IgG expression. *p < 0.05 vs. Control group; #p < 0.05 vs. Model group; @p < 0.05 vs. BM-MSCs-Exos group.
![Figure 5. Overexpression of FGL1 attenuated inflammatory cytokines, specific rheumatoid markers and immunological markers expressions in RA rat model. (a) MMP-9 expression; (b) IL-1β expression; (c) IL-8 expression; (d) IL-17 expression; (e) RF expression; (f) MMP-3 expression; (g) CRP expression; (h) IgG expression. *p < 0.05 vs. Control group; #p < 0.05 vs. Model group; @p < 0.05 vs. BM-MSCs-Exos group.](/cms/asset/0d4dc64c-90d7-4a2e-8637-bd0d8ec805f3/kbie_a_2090379_f0005_b.gif)
Figure 6. Overexpression of FGL1 attenuated cell apoptosis and FGL1 expression in RA rat model. (a) Cell apoptosis in knee joint; (b) FGL1 expression in knee joint. *p < 0.05 vs. Control group; #p < 0.05 vs. Model group; @p < 0.05 vs. BM-MSCs-Exos group.
![Figure 6. Overexpression of FGL1 attenuated cell apoptosis and FGL1 expression in RA rat model. (a) Cell apoptosis in knee joint; (b) FGL1 expression in knee joint. *p < 0.05 vs. Control group; #p < 0.05 vs. Model group; @p < 0.05 vs. BM-MSCs-Exos group.](/cms/asset/67b4b7de-d224-4f99-808b-1381a7cb2094/kbie_a_2090379_f0006_oc.jpg)
Figure 7. Overexpression of FGL1 attenuated immune organs and NF-κB relative protein expressions in RA rat model. A: Thymus indexes; B: Spleen indexes; C: Liver and thymus histopathology were detected by HE staining; *p < 0.05 vs. Control group; #p < 0.05 vs. Model group; @p < 0.05 vs. BM-MSCs-Exos group.
![Figure 7. Overexpression of FGL1 attenuated immune organs and NF-κB relative protein expressions in RA rat model. A: Thymus indexes; B: Spleen indexes; C: Liver and thymus histopathology were detected by HE staining; *p < 0.05 vs. Control group; #p < 0.05 vs. Model group; @p < 0.05 vs. BM-MSCs-Exos group.](/cms/asset/b8bf3a84-a053-4c4b-9c1c-486500fb7f36/kbie_a_2090379_f0007_oc.jpg)
Figure 8. Overexpression of FGL1 attenuated NF-κB relative protein expressions in RA rat model. (a and b) p-NF-κBp65 and NF-κBp65 expressions were detected by Western blot; (c) Western blot images; (d) p-IκBα/IκBα; (e) Bcl-2/Bax; (f) cleaved-caspase 3 expression. *p < 0.05 vs. Control group; #p < 0.05 vs. Model group; @p < 0.05 vs. BM-MSCs-Exos group.
![Figure 8. Overexpression of FGL1 attenuated NF-κB relative protein expressions in RA rat model. (a and b) p-NF-κBp65 and NF-κBp65 expressions were detected by Western blot; (c) Western blot images; (d) p-IκBα/IκBα; (e) Bcl-2/Bax; (f) cleaved-caspase 3 expression. *p < 0.05 vs. Control group; #p < 0.05 vs. Model group; @p < 0.05 vs. BM-MSCs-Exos group.](/cms/asset/395a8841-bcca-4dc6-b580-6ae1c0507f78/kbie_a_2090379_f0008_b.gif)